Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.
Authors
Haidry, R JButt, M A
Dunn, J M
Gupta, A
Lipman, G
Smart, H L
Bhandari, P
Smith, L
Willert, R
Fullarton, G
Di Pietro, M
Gordon, C
Penman, I
Barr, H
Patel, P
Kapoor, N
Hoare, J
Narayanasamy, R
Ang, Y
Veitch, A
Ragunath, K
Novelli, M
Lovat, L B
Issue Date
2015-08Keywords
CANCER, OESOPAHGEALMeSH
AdenocarcinomaAdult
Aged
Aged, 80 and over
Barrett Esophagus
Catheter Ablation
Disease Progression
Esophageal Neoplasms
Esophagoscopy
Female
Follow-Up Studies
Great Britain
Humans
Male
Middle Aged
Precancerous Conditions
Prospective Studies
Registries
Time Factors
Treatment Outcome
Metadata
Show full item recordCitation
Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. 2015, 64 (8):1192-9 GutPublisher
BMJJournal
GutDOI
10.1136/gutjnl-2014-308501PubMed ID
25539672Abstract
Barrett's oesophagus (BE) is a pre-malignant condition leading to oesophageal adenocarcinoma (OAC). Treatment of neoplasia at an early stage is desirable. Combined endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) is an alternative to surgery for patients with BE-related neoplasia.Item Type
ArticleLanguage
enISSN
1468-3288ae974a485f413a2113503eed53cd6c53
10.1136/gutjnl-2014-308501